Emerging Role of IL-10 in Hypertrophic Scars
Authors:
Open Access
- 27 August 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7
Abstract
Hypertrophic scars (HS) arise from traumatic or surgical injuries and the subsequent abnormal wound healing, which is characterized by continuous and histologically localized inflammation. Therefore, inhibiting local inflammation is an effective method of treating HS. Recent insight into the role of interleukin-10 (IL-10), an important anti-inflammatory cytokine, in fibrosis has increased our understanding of the pathophysiology of HS and has suggested new therapeutic targets. This review summarizes the recent progress in elucidating the role of IL-10 in the formation of HS and its therapeutic potential based on current research. This knowledge will enhance our understanding of the role of IL-10 in scar formation and shed new light on the regulation and potential treatment of HS.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20191138, BK20191141)
This publication has 57 references indexed in Scilit:
- Functionalized Scaffold-mediated Interleukin 10 Gene Delivery Significantly Improves Survival Rates of Stem Cells In VivoMolecular Therapy, 2011
- Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathologyJournal of Experimental Medicine, 2011
- Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated InflammationImmunity, 2011
- Structure and Mechanism of Receptor Sharing by the IL-10R2 Common ChainStructure, 2010
- Factors Affecting Wound HealingJournal of Dental Research, 2010
- Permissive environment in postnatal wounds induced by adenoviral‐mediated overexpression of the anti‐inflammatory cytokine interleukin‐10 prevents scar formationWound Repair and Regeneration, 2007
- Accelerated Wound Closure in Mice Deficient for Interleukin-10The American Journal of Pathology, 2007
- Leukocyte-Derived IL-10 Reduces Subepithelial Fibrosis Associated with Chronically Inhaled EndotoxinAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- IL-10 gene therapy prevents TNBS-induced colitisGene Therapy, 2002
- Effect of Interleukin-10 on the Gene Expression of Type I Collagen, Fibronectin, and Decorin in Human Skin Fibroblasts: Differential Regulation by Transforming Growth Factor-β and Monocyte Chemoattractant Protein-1Biochemical and Biophysical Research Communications, 2001